October 25, 2010 “Intelligence: Late Breaking Lab News”

Southern California’s always-crazy lab testing marketplace has a new laboratory competitor. In recent months, Richard Nicholson re-entered the business by acquiring West Pacific Medical Laboratory, based in Santa Fe Springs, California. He is assembling a team of experienced professionals to put his new laboratory company on the path to sustained growth.

MORE ON: Nicholson

Nicholson is best-known for his successful leadership at Santa Ana-based Westcliff Medical Laboratories, Inc., prior to its sale to a private equity group in 2006. He has a reputation for conservative managed care contracting practices. During the 1990s and into the 2000s, Westcliff grew at a constant pace and was one of the most profitable of California’s independent laboratory companies. Nicholson’s return via West Pacific Medical Laboratory indicates that he sees continued opportunity in Southern California’s intensely-competitive market for physicians’ office lab test referrals.


In Austin, Texas, Austin- based Rules-Based Medicine Inc., announced a diagnostic assay that uses a blood specimen to aid in diagnosing schizophrenia. Called VeriPsych, the lab test incorporates “the simultaneous measurement of 51 different protein and hormone bio- markers with an associated mathematical decision rule.” Offered as a laboratory developed test (LDT), RMB says it will be used to affirm the “physician’s clinical analysis.”


  • Vermillion, Inc., of Austin, Texas, has hired Jeffrey M. Salzman to be Corporate Director of Reimbursement. Salzman served most recently at Ipsogen, Inc. He has experience at Monogram BioSciences, Quest Diagnostics Incorporated, Prudential Healthcare, and Humana.
  • Daniel R. Forche joined CombiMatrix Corporation of Irvine, California, to be its new Senior Vice President of Sales and Marketing. Forche was most recently at Agendia, Inc. He earlier worked at US Laboratories, Ventana Medical Systems, Abbott Laboratories, and InSight Health Corporation.

Dark Daily Update

dark_daily_logoHave you caught the latest e-briefings from DARK Daily? If so, then you’d know about…

General Electric’s acquisition of Clarient, Inc., for $587 million. The acquisition positions GE to combine Clarient’s molecular pathology technology with GE’s molecular imaging technology.

You can get the free DARK Daily e-briefings by signing up at www.darkdaily.com.


Leave a Reply


You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

Privacy Policy: We will never share your personal information.